Abcam (ABCZF) Preferred Dividends : $0.0 Mil (TTM As of Jun. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Abcam Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Abcam's preferred dividends for the six months ended in Jun. 2023 was $0.0 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2023 was $0.0 Mil.

Abcam Preferred Dividends Historical Data

The historical data trend for Abcam's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abcam Preferred Dividends Chart

Abcam Annual Data

Trend

Jun12

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec22

Preferred Dividends

Get a 7-Day Free Trial

Abcam Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Jun22	Dec22	Jun23
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Abcam Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Abcam (OTCPK:ABCZF) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

Abcam (ABCZF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abcam PLC (OTCPK:ABCZF) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

N/A

Address

Discovery Drive, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AX

Website

https://www.abcam.com

Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.